BioAdaptives confirms first commercial orders for XcellaraHeart
BioAdaptives says it has confirmed its first commercial orders of XcellaraHeart, and it provided an update on capital restructuring progress.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.